Replies to post #165359 on Biotech Values

[DewDiligence]

PTLA hopes they can get FDA approval for PRT-4445 based a single 100-200-patient PD study and that efficacy studies in bleeding patients can be done on a post-marketing basis. I think they’re dreaming.